Article
ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration.
Molecular vision - 1 Jan 2017
Nakai Shunichiro, Honda Shigeru, Matsumiya Wataru, Miki Akiko, Nakamura Makoto
Abstract excerpt
PURPOSE: To determine the association of age-related maculopathy susceptibility2 (ARMS2) gene polymorphisms with the 3-year outcomes of photodynamic therapy (PDT) in wet age-related macular degeneration (wet AMD). METHODS: The single nucleotide polymorphism (SNP) at rs10490924 in the ARMS2 gene of 65 patients with wet AMD who underwent PDT was genotyped using the TaqMan assay. The clinical characteristics and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
